提醒成功
微信/QQ登录
搜索
首页
| 产品规范 | |
|---|---|
| Type | In Vivo - Reseach Grade Antibody |
| Host | CHO cells |
| catalog# | B00008 |
| Application | Flow cytometry, animal model study |
| Aliases | Nulojix, CTLA-4 Fc Fusion Protein |
| Size/Concentration | 1mg/5mg/20mg |
| Storage | Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Formulation | PBS, pH 7.4 |
Description |
|---|
Belatacept (trade name Nulojix, Bristol-Myers-Squibb), a fusion protein of a Fc fragment (human IgG1 isotype) and the extracellular domain of CTLA-4, can be used to extend graft survival while limiting the toxicity generated by standard immune suppressing regimens, such as calcineurin inhibitors. Belatacept differs from abatacept (trade name Orencia) by only 2 amino acids. The CTLA-4 protein is important for T-cell costimulation and selectively blocks the process of T-cell activation. |
Belatacept Biosimilar B00008
规格：
- 1mg
- 5mg
- 20mg
数量：
-
+
说明书：
¥5200
-
分享
-
咨询
-
收藏
联系方式
CONTACT-
联系电话:
0731-88388785 -
公司邮箱:
sales@promab.cn -
公司地址:
湖南省长沙市高新开发区林语路239号顺畅产业园5楼
湖南省长沙市望城区普瑞大道8号出版科技园2号楼
官方微信
产品中心
Product技术服务
service客户留言
message